about
The prevalence and clinicopathological features of breast cancer patients with hepatitis B virus infection in China.Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis.Implication from thyroid function decreasing during chemotherapy in breast cancer patients: chemosensitization role of triiodothyronine.On the status and comparison of glucose intolerance in female breast cancer patients at initial diagnosis and during chemotherapy through an oral glucose tolerance test.Discordance and clinical significance of ER, PR, and HER2 status between primary breast cancer and synchronous axillary lymph node metastasis.Does hepatitis B virus infection cause breast cancer?Thyrotoxicosis Occurring in Secondary Hyperparathyroidism Patients Undergoing Dialysis after Total Parathyroidectomy with AutotransplantationA Novel Antiviral Treatment of Hepatitis C Virus Reactivation in a Breast Cancer Patient Undergoing Chemotherapy.Negative genic switch of HER-2 in the primary tumor instead of the synchronous metastatic nodal lesions after neoadjuvant chemotherapy in a patient with primary HER2-positive breast cancer.Clinical study on the relationship between hepatitis B virus infection and risk of breast cancer: a large sized case-control and single center study in southwest of China.Incidences of diabetes and prediabetes among female adult breast cancer patients after systemic treatment.Clinicopathologic features of breast cancer patients with type 2 diabetes mellitus in southwest of China.Study on the status of thyroid function and thyroid nodules in chinese breast cancer patients.Diagnosis prevention and treatment for PICC-related upper extremity deep vein thrombosis in breast cancer patients.Prophylactic effect of lamivudine on chemotherapy-induced hepatitis B virus reactivation in patients with solid tumour: A meta-analysis.Chemosensitization role of fulvestrant in combination with chemotherapy in postmenopausal hormone receptor positive and human epidermal growth factor negative metastatic breast cancer.Clinical study on the prevalence and comparative analysis of metabolic syndrome and its components among Chinese breast cancer women and control population.On the status of β-cell dysfunction and insulin resistance of breast cancer patient without history of diabetes after systemic treatment.Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy.Tidal chemotherapy in premenopausal patients with hormone receptor positive breast cancer.Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysisSignificantly higher pathologic complete response (pCR) after the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: Evidence from a meta-analysis of randomized controlled trialsEffect of neoadjuvant chemotherapy on the expression of hormone receptors and Ki-67 in Chinese breast cancer patients: A retrospective study of 525 patients.On the proportion of male breast cancer among all breast cancersDiagnostic criteria should be considered when reviewing the effect of diabetes prevention studiesClinical study on the status of transient thyrotoxicosis after surgery for secondary hyperparathyroidism patients with end-stage renal disease and normal thyroid functionCognitive impairments in breast cancer survivors treated with chemotherapy: a study based on event-related potentialsComment on Norhammar et al. Undetected Dysglycemia Is an Important Risk Factor for Two Common Diseases, Myocardial Infarction and Periodontitis: A Report From the PAROKRANK Study. Diabetes Care 2019;42:1504-1511A population-based study of the relationship between endometrial thickness and prevalence of breast mass in postmenopausal womenComment on Hubbard et al. Prediabetes and Risk for Cardiovascular Disease by Hypertension Status in Black Adults: The Jackson Heart Study. Diabetes Care 2019;42:2322-2329Lifestyle intervention and impaired glucose tolerance in the Da Qing studyHigh-Dose Vitamin D Supplementation and Bone Health
P50
Q33566869-520B5C47-51F9-4E04-81FF-37BE39387FA9Q33825391-6A9C1E47-F05B-42A5-AD81-AC4B8B1CFFDEQ34799909-3355A498-B453-40CB-AA8E-0F2B0B8FE776Q35137438-C16D9ADC-77B5-4ED2-93A5-B9F6DA3390F1Q38168792-8D4B519F-DB41-46B9-9636-433CF9D9603EQ40517435-F51B7721-C256-4FAF-82AC-109E17B6F40BQ41377302-7B5224C0-3823-4F1E-95E6-EC055BF972A7Q42345319-C6F3E961-B13F-4C80-823C-82C79DC49430Q42669105-BBE72672-FD73-486E-8D59-6377F825B9F6Q42700839-FFA3072D-E19C-44FE-9B44-3B74FF931B6EQ45111043-D276EC18-93FD-4F47-A10D-8028098FB626Q46098998-78D7F164-2C63-4852-8C69-DAF1AB75294EQ47105000-10FA32AD-09B4-472D-AF28-92CCD6C72A01Q47257165-93E742C9-A859-4E08-BA98-C3CCDF163A23Q47562286-F6368FD5-C641-41DC-B862-E7C8224E5847Q47616710-2DD744AF-1226-4D31-806F-9AFAD068D984Q50292353-894B5817-65EE-47F9-9674-2B9CABE3C395Q51324129-CFB70B0C-0AAE-4878-B898-311C3B76644BQ52573933-6650A4B1-FB60-497F-AC63-3895DAAABBCCQ52772463-776B23D4-C19C-4E63-A5F6-4F802D788C79Q57491827-FB18CEF3-5E2B-404C-B3C3-F2EBAE49B908Q58798350-E5498507-B5E5-4964-BD52-CBAFF5D5127BQ64893434-F0FB1031-27F5-43E7-ADE5-79CBEE6E066FQ89505917-8D50E137-65B2-4038-BDC6-6BD52B2391A7Q90084370-916B30E1-52EE-4570-9498-CFB24F5AC6C8Q90403936-AEED6ADC-E1BC-4988-A0C6-8C55CA966DBAQ91346872-E782A0D8-B95C-4B50-B887-45578F0F0398Q92162334-B5A339CD-869C-4686-AB18-E1A53B8CBEA9Q92711873-F58D6D3E-7861-4633-A68A-C1795DEDCE64Q92781561-5011F63F-741B-4885-A10E-6AEA8DE3AE95Q92791513-FD8D51BF-0AD3-4C64-957E-D3CBF765E33CQ95591435-DB2C14AF-790E-4C08-A5D6-54D83A986B64
P50
description
researcher ORCID ID = 0000-0001-5705-9001
@en
wetenschapper
@nl
name
Ling-Quan Kong
@ast
Ling-Quan Kong
@en
Ling-Quan Kong
@es
Ling-Quan Kong
@nl
type
label
Ling-Quan Kong
@ast
Ling-Quan Kong
@en
Ling-Quan Kong
@es
Ling-Quan Kong
@nl
prefLabel
Ling-Quan Kong
@ast
Ling-Quan Kong
@en
Ling-Quan Kong
@es
Ling-Quan Kong
@nl
P106
P1153
7201533011
P31
P496
0000-0001-5705-9001